Reported results
- Net sales increased 4% to $509.4 million, while Adjusted net sales increased 6% to $517.9 million.
- Operating income increased 12% to $61.0 million, and Adjusted operating income increased 35% to $90.0 million.
- Net income increased 13% to $44.4 million, and Adjusted net income increased 35% to $67.2 million.
- Net income per diluted share increased 25% to $0.60, and Adjusted net income per diluted share increased 49% to $0.91.
- Gross margin increased 180 basis points to 57.7%, and Adjusted gross margin increased 310 basis points to 59.0%.
Guidance
- Adjusted sales growth of approximately 6%
- Adjusted operating income margin of approximately 14.9%
- Adjusted net income per diluted share of $2.90 to $2.95
- Free cash flow of $200 million to $225 million
Notes
Beginning in the third quarter of 2026, product recall reserve adjustments related to 2023 voluntary recalls are excluded from non-GAAP financial measures, representing a change from the approach adopted with fourth quarter 2025 results.
Price and volatility reaction
The stock moved -10.5% on the print. No front-expiry chain was on file, so there is no straddle expected move.
| Measure | Value | Basis |
|---|---|---|
| Close before release | 42.79 | 2026-11-11 |
| Close after release | 38.3 | 2026-11-12 |
| Realised move | -10.5% | close to close |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-12 (8-K, Item 2.02). Read the original filing on sec.gov.
